Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery
Clinical trial NCT06780592 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06780592
- Sponsor
- Huashan Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-13
- Primary completion
- 2025-12-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.